nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Carmustine—melanoma	0.269	0.417	CbGbCtD
Phenylephrine—CYP1A2—Vemurafenib—melanoma	0.212	0.33	CbGbCtD
Phenylephrine—CYP1A2—Dacarbazine—melanoma	0.163	0.253	CbGbCtD
Phenylephrine—Hyperaemia—Carmustine—melanoma	0.00817	0.0508	CcSEcCtD
Phenylephrine—Skin necrosis—Carmustine—melanoma	0.00706	0.0439	CcSEcCtD
Phenylephrine—Rales—Bleomycin—melanoma	0.00689	0.0428	CcSEcCtD
Phenylephrine—Isoprenaline—MAPK1—melanoma	0.00427	0.808	CrCbGaD
Phenylephrine—Extravasation—Bleomycin—melanoma	0.00324	0.0201	CcSEcCtD
Phenylephrine—Extravasation—Dactinomycin—melanoma	0.00302	0.0188	CcSEcCtD
Phenylephrine—Extravasation—Carmustine—melanoma	0.00283	0.0176	CcSEcCtD
Phenylephrine—Skin exfoliation—Bleomycin—melanoma	0.0027	0.0168	CcSEcCtD
Phenylephrine—Lacrimation—Docetaxel—melanoma	0.0027	0.0168	CcSEcCtD
Phenylephrine—Neck pain—Carmustine—melanoma	0.0025	0.0155	CcSEcCtD
Phenylephrine—Skin exfoliation—Carmustine—melanoma	0.00236	0.0146	CcSEcCtD
Phenylephrine—Skin exfoliation—Temozolomide—melanoma	0.00228	0.0141	CcSEcCtD
Phenylephrine—Cardiac disorder—Vemurafenib—melanoma	0.00217	0.0135	CcSEcCtD
Phenylephrine—Angiopathy—Vemurafenib—melanoma	0.00213	0.0132	CcSEcCtD
Phenylephrine—Mediastinal disorder—Vemurafenib—melanoma	0.00211	0.0131	CcSEcCtD
Phenylephrine—Dysgeusia—Vemurafenib—melanoma	0.002	0.0124	CcSEcCtD
Phenylephrine—Eye pain—Carmustine—melanoma	0.00198	0.0123	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Docetaxel—melanoma	0.00197	0.0123	CcSEcCtD
Phenylephrine—Eye pain—Temozolomide—melanoma	0.00192	0.0119	CcSEcCtD
Phenylephrine—Eye irritation—Docetaxel—melanoma	0.00186	0.0115	CcSEcCtD
Phenylephrine—Extravasation—Docetaxel—melanoma	0.00182	0.0113	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00172	0.0107	CcSEcCtD
Phenylephrine—Lacrimation increased—Docetaxel—melanoma	0.00172	0.0107	CcSEcCtD
Phenylephrine—Nervous system disorder—Vemurafenib—melanoma	0.00163	0.0101	CcSEcCtD
Phenylephrine—Skin disorder—Vemurafenib—melanoma	0.00162	0.01	CcSEcCtD
Phenylephrine—Blood pressure increased—Docetaxel—melanoma	0.00159	0.00986	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Bleomycin—melanoma	0.00156	0.00969	CcSEcCtD
Phenylephrine—Myocardial infarction—Bleomycin—melanoma	0.00155	0.00963	CcSEcCtD
Phenylephrine—Skin exfoliation—Docetaxel—melanoma	0.00151	0.00941	CcSEcCtD
Phenylephrine—Sweating increased—Temozolomide—melanoma	0.00146	0.00906	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00144	0.00893	CcSEcCtD
Phenylephrine—Pulmonary oedema—Docetaxel—melanoma	0.00141	0.00877	CcSEcCtD
Phenylephrine—Hypersensitivity—Vemurafenib—melanoma	0.00123	0.00762	CcSEcCtD
Phenylephrine—Visual disturbance—Docetaxel—melanoma	0.00121	0.00755	CcSEcCtD
Phenylephrine—Visual impairment—Carmustine—melanoma	0.00119	0.00742	CcSEcCtD
Phenylephrine—Pruritus—Vemurafenib—melanoma	0.00118	0.00732	CcSEcCtD
Phenylephrine—Visual impairment—Temozolomide—melanoma	0.00115	0.00717	CcSEcCtD
Phenylephrine—Cardiac disorder—Temozolomide—melanoma	0.00111	0.00691	CcSEcCtD
Phenylephrine—Arrhythmia—Carmustine—melanoma	0.00111	0.00688	CcSEcCtD
Phenylephrine—Dizziness—Vemurafenib—melanoma	0.0011	0.00684	CcSEcCtD
Phenylephrine—Angiopathy—Temozolomide—melanoma	0.00109	0.00675	CcSEcCtD
Phenylephrine—Mental disorder—Carmustine—melanoma	0.00109	0.00675	CcSEcCtD
Phenylephrine—Immune system disorder—Temozolomide—melanoma	0.00108	0.00672	CcSEcCtD
Phenylephrine—Mediastinal disorder—Temozolomide—melanoma	0.00108	0.00671	CcSEcCtD
Phenylephrine—Vomiting—Vemurafenib—melanoma	0.00106	0.00658	CcSEcCtD
Phenylephrine—Chest pain—Bleomycin—melanoma	0.00105	0.00654	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Docetaxel—melanoma	0.00105	0.00653	CcSEcCtD
Phenylephrine—Abdominal pain upper—Docetaxel—melanoma	0.00105	0.00653	CcSEcCtD
Phenylephrine—Rash—Vemurafenib—melanoma	0.00105	0.00652	CcSEcCtD
Phenylephrine—Mental disorder—Temozolomide—melanoma	0.00105	0.00652	CcSEcCtD
Phenylephrine—Dermatitis—Vemurafenib—melanoma	0.00105	0.00652	CcSEcCtD
Phenylephrine—Headache—Vemurafenib—melanoma	0.00104	0.00648	CcSEcCtD
Phenylephrine—Dysgeusia—Temozolomide—melanoma	0.00102	0.00634	CcSEcCtD
Phenylephrine—Vision blurred—Carmustine—melanoma	0.00102	0.00632	CcSEcCtD
Phenylephrine—Epinephrine—TNF—melanoma	0.00101	0.192	CrCbGaD
Phenylephrine—Tremor—Carmustine—melanoma	0.00101	0.00628	CcSEcCtD
Phenylephrine—Agitation—Carmustine—melanoma	0.000991	0.00616	CcSEcCtD
Phenylephrine—Nausea—Vemurafenib—melanoma	0.000988	0.00615	CcSEcCtD
Phenylephrine—Vision blurred—Temozolomide—melanoma	0.000982	0.00611	CcSEcCtD
Phenylephrine—Tremor—Temozolomide—melanoma	0.000976	0.00607	CcSEcCtD
Phenylephrine—Agitation—Temozolomide—melanoma	0.000958	0.00595	CcSEcCtD
Phenylephrine—Hypertension—Carmustine—melanoma	0.000931	0.00579	CcSEcCtD
Phenylephrine—Palpitations—Temozolomide—melanoma	0.000921	0.00573	CcSEcCtD
Phenylephrine—Chest pain—Carmustine—melanoma	0.000918	0.00571	CcSEcCtD
Phenylephrine—Paraesthesia—Bleomycin—melanoma	0.000905	0.00563	CcSEcCtD
Phenylephrine—Hypertension—Temozolomide—melanoma	0.0009	0.00559	CcSEcCtD
Phenylephrine—Dyspnoea—Bleomycin—melanoma	0.000899	0.00559	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000881	0.00548	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Docetaxel—melanoma	0.000874	0.00544	CcSEcCtD
Phenylephrine—Myocardial infarction—Docetaxel—melanoma	0.000869	0.0054	CcSEcCtD
Phenylephrine—Pain—Bleomycin—melanoma	0.000862	0.00536	CcSEcCtD
Phenylephrine—Tachycardia—Carmustine—melanoma	0.000859	0.00534	CcSEcCtD
Phenylephrine—Nervous system disorder—Temozolomide—melanoma	0.000834	0.00519	CcSEcCtD
Phenylephrine—Skin disorder—Temozolomide—melanoma	0.000826	0.00514	CcSEcCtD
Phenylephrine—Hyperhidrosis—Temozolomide—melanoma	0.000822	0.00511	CcSEcCtD
Phenylephrine—Pain—Dactinomycin—melanoma	0.000804	0.005	CcSEcCtD
Phenylephrine—Urticaria—Bleomycin—melanoma	0.000801	0.00498	CcSEcCtD
Phenylephrine—Paraesthesia—Carmustine—melanoma	0.00079	0.00491	CcSEcCtD
Phenylephrine—Dyspnoea—Carmustine—melanoma	0.000785	0.00488	CcSEcCtD
Phenylephrine—Visual impairment—Docetaxel—melanoma	0.000767	0.00477	CcSEcCtD
Phenylephrine—Paraesthesia—Temozolomide—melanoma	0.000764	0.00475	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Carmustine—melanoma	0.00076	0.00472	CcSEcCtD
Phenylephrine—Dyspnoea—Temozolomide—melanoma	0.000758	0.00471	CcSEcCtD
Phenylephrine—Pain—Carmustine—melanoma	0.000753	0.00468	CcSEcCtD
Phenylephrine—Hypersensitivity—Bleomycin—melanoma	0.000743	0.00462	CcSEcCtD
Phenylephrine—Cardiac disorder—Docetaxel—melanoma	0.000739	0.00459	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Temozolomide—melanoma	0.000734	0.00457	CcSEcCtD
Phenylephrine—Pain—Temozolomide—melanoma	0.000727	0.00452	CcSEcCtD
Phenylephrine—Angiopathy—Docetaxel—melanoma	0.000722	0.00449	CcSEcCtD
Phenylephrine—Immune system disorder—Docetaxel—melanoma	0.000719	0.00447	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—melanoma	0.000717	0.00446	CcSEcCtD
Phenylephrine—Pruritus—Bleomycin—melanoma	0.000713	0.00444	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—melanoma	0.000711	0.00442	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—melanoma	0.000697	0.00434	CcSEcCtD
Phenylephrine—Hypersensitivity—Dactinomycin—melanoma	0.000693	0.00431	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—melanoma	0.000679	0.00422	CcSEcCtD
Phenylephrine—Urticaria—Temozolomide—melanoma	0.000676	0.0042	CcSEcCtD
Phenylephrine—Hypersensitivity—Carmustine—melanoma	0.000648	0.00403	CcSEcCtD
Phenylephrine—Vomiting—Bleomycin—melanoma	0.000641	0.00399	CcSEcCtD
Phenylephrine—Rash—Bleomycin—melanoma	0.000636	0.00395	CcSEcCtD
Phenylephrine—Dermatitis—Bleomycin—melanoma	0.000635	0.00395	CcSEcCtD
Phenylephrine—Hypersensitivity—Temozolomide—melanoma	0.000627	0.0039	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—melanoma	0.000621	0.00386	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—melanoma	0.000612	0.00381	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—melanoma	0.000609	0.00379	CcSEcCtD
Phenylephrine—Pruritus—Temozolomide—melanoma	0.000602	0.00374	CcSEcCtD
Phenylephrine—Nausea—Bleomycin—melanoma	0.000599	0.00372	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—melanoma	0.000598	0.00372	CcSEcCtD
Phenylephrine—Vomiting—Dactinomycin—melanoma	0.000598	0.00372	CcSEcCtD
Phenylephrine—Rash—Dactinomycin—melanoma	0.000593	0.00369	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—melanoma	0.00059	0.00367	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000586	0.00364	CcSEcCtD
Phenylephrine—Dizziness—Carmustine—melanoma	0.000582	0.00362	CcSEcCtD
Phenylephrine—Dizziness—Temozolomide—melanoma	0.000562	0.0035	CcSEcCtD
Phenylephrine—Vomiting—Carmustine—melanoma	0.00056	0.00348	CcSEcCtD
Phenylephrine—Nausea—Dactinomycin—melanoma	0.000559	0.00347	CcSEcCtD
Phenylephrine—Shock—Docetaxel—melanoma	0.000556	0.00346	CcSEcCtD
Phenylephrine—Rash—Carmustine—melanoma	0.000555	0.00345	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—melanoma	0.000555	0.00345	CcSEcCtD
Phenylephrine—Dermatitis—Carmustine—melanoma	0.000554	0.00345	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—melanoma	0.000552	0.00343	CcSEcCtD
Phenylephrine—Headache—Carmustine—melanoma	0.000551	0.00343	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—melanoma	0.000549	0.00342	CcSEcCtD
Phenylephrine—Vomiting—Temozolomide—melanoma	0.000541	0.00336	CcSEcCtD
Phenylephrine—Rash—Temozolomide—melanoma	0.000536	0.00333	CcSEcCtD
Phenylephrine—Dermatitis—Temozolomide—melanoma	0.000536	0.00333	CcSEcCtD
Phenylephrine—Headache—Temozolomide—melanoma	0.000533	0.00331	CcSEcCtD
Phenylephrine—Nausea—Carmustine—melanoma	0.000523	0.00325	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—melanoma	0.000508	0.00316	CcSEcCtD
Phenylephrine—Nausea—Temozolomide—melanoma	0.000505	0.00314	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—melanoma	0.000504	0.00314	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—melanoma	0.000488	0.00304	CcSEcCtD
Phenylephrine—Pain—Docetaxel—melanoma	0.000484	0.00301	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—melanoma	0.000417	0.00259	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—melanoma	0.0004	0.00249	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—melanoma	0.000374	0.00233	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—melanoma	0.00036	0.00224	CcSEcCtD
Phenylephrine—Rash—Docetaxel—melanoma	0.000357	0.00222	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—melanoma	0.000356	0.00222	CcSEcCtD
Phenylephrine—Headache—Docetaxel—melanoma	0.000354	0.0022	CcSEcCtD
Phenylephrine—Nausea—Docetaxel—melanoma	0.000336	0.00209	CcSEcCtD
Phenylephrine—ADRA1D—Signaling Pathways—MAP2K2—melanoma	3.78e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CG—melanoma	3.78e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL8—melanoma	3.78e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SOCS1—melanoma	3.78e-05	0.000199	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAP2K1—melanoma	3.77e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—S100B—melanoma	3.77e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CD—melanoma	3.74e-05	0.000197	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CG—melanoma	3.71e-05	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SYK—melanoma	3.69e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CD—melanoma	3.66e-05	0.000193	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ITGAV—melanoma	3.62e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NGFR—melanoma	3.62e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT3—melanoma	3.62e-05	0.000191	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLA2G6—melanoma	3.62e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—melanoma	3.61e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB4—melanoma	3.6e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TERT—melanoma	3.6e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CB—melanoma	3.59e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAC1—melanoma	3.59e-05	0.000189	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—melanoma	3.59e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN2B—melanoma	3.57e-05	0.000188	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CD86—melanoma	3.45e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL8—melanoma	3.45e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HIF1A—melanoma	3.44e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDN1—melanoma	3.43e-05	0.00018	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SOCS1—melanoma	3.35e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CSF2—melanoma	3.35e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGF1—melanoma	3.35e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAP2K1—melanoma	3.35e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—S100B—melanoma	3.35e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CD—melanoma	3.32e-05	0.000175	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—melanoma	3.3e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KDR—melanoma	3.29e-05	0.000173	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—E2F1—melanoma	3.28e-05	0.000173	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CD—melanoma	3.27e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CB—melanoma	3.26e-05	0.000172	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—VCAN—melanoma	3.25e-05	0.000171	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDGFRA—melanoma	3.24e-05	0.000171	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—melanoma	3.22e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ITGB3—melanoma	3.21e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRKCA—melanoma	3.21e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB4—melanoma	3.2e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CB—melanoma	3.19e-05	0.000168	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN2B—melanoma	3.17e-05	0.000167	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FN1—melanoma	3.17e-05	0.000167	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SPP1—melanoma	3.15e-05	0.000166	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAP2K2—melanoma	3.14e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—melanoma	3.13e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—melanoma	3.1e-05	0.000163	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.08e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD86—melanoma	3.07e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—melanoma	3.07e-05	0.000161	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDN1—melanoma	3.04e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CD80—melanoma	3.04e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—melanoma	3.03e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KIT—melanoma	3.03e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APC—melanoma	3.03e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—NRAS—melanoma	3.03e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—melanoma	3e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGF—melanoma	2.99e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—melanoma	2.98e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAC1—melanoma	2.98e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF1—melanoma	2.97e-05	0.000157	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CSF2—melanoma	2.97e-05	0.000157	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.97e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—melanoma	2.93e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—E2F1—melanoma	2.91e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—melanoma	2.9e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—melanoma	2.9e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDGFRA—melanoma	2.88e-05	0.000152	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HIF1A—melanoma	2.85e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ITGB3—melanoma	2.85e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRKCA—melanoma	2.85e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BRAF—melanoma	2.85e-05	0.00015	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—melanoma	2.85e-05	0.00015	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—melanoma	2.82e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SPP1—melanoma	2.8e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAP2K2—melanoma	2.79e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—melanoma	2.78e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—melanoma	2.77e-05	0.000146	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK1—melanoma	2.76e-05	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—melanoma	2.76e-05	0.000145	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP17A1—melanoma	2.74e-05	0.000144	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—melanoma	2.73e-05	0.000144	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.7e-05	0.000142	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAP2K1—melanoma	2.68e-05	0.000141	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.67e-05	0.000141	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—melanoma	2.66e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—melanoma	2.66e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—melanoma	2.65e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAC1—melanoma	2.64e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—melanoma	2.64e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FN1—melanoma	2.63e-05	0.000138	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—melanoma	2.61e-05	0.000137	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNA11—melanoma	2.59e-05	0.000136	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—melanoma	2.57e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGF2—melanoma	2.55e-05	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HIF1A—melanoma	2.54e-05	0.000134	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—FASN—melanoma	2.53e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CD80—melanoma	2.52e-05	0.000133	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APC—melanoma	2.51e-05	0.000132	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—melanoma	2.51e-05	0.000132	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KIT—melanoma	2.51e-05	0.000132	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—NRAS—melanoma	2.51e-05	0.000132	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC5A5—melanoma	2.49e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGF—melanoma	2.49e-05	0.000131	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—melanoma	2.46e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—melanoma	2.42e-05	0.000128	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—melanoma	2.41e-05	0.000127	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CD44—melanoma	2.41e-05	0.000127	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNAQ—melanoma	2.41e-05	0.000127	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—melanoma	2.4e-05	0.000126	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MDM2—melanoma	2.39e-05	0.000126	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BRAF—melanoma	2.36e-05	0.000124	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.36e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB2—melanoma	2.35e-05	0.000124	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.34e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FN1—melanoma	2.33e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—melanoma	2.32e-05	0.000122	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1B1—melanoma	2.31e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—melanoma	2.3e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK1—melanoma	2.29e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—melanoma	2.29e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—melanoma	2.28e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD80—melanoma	2.24e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APC—melanoma	2.23e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—melanoma	2.23e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KIT—melanoma	2.23e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—NRAS—melanoma	2.23e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—melanoma	2.23e-05	0.000118	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAP2K1—melanoma	2.23e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—melanoma	2.22e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—melanoma	2.21e-05	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGF—melanoma	2.21e-05	0.000116	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—melanoma	2.19e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1B—melanoma	2.18e-05	0.000115	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—melanoma	2.16e-05	0.000114	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—melanoma	2.16e-05	0.000114	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—melanoma	2.14e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—melanoma	2.14e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—melanoma	2.13e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—melanoma	2.12e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGF2—melanoma	2.12e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BRAF—melanoma	2.1e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—melanoma	2.08e-05	0.000109	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CTNNB1—melanoma	2.06e-05	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—melanoma	2.05e-05	0.000108	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.04e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK1—melanoma	2.04e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—melanoma	2.04e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—melanoma	2.02e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—melanoma	2.01e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—melanoma	2.01e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NFKB1—melanoma	2e-05	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	1.99e-05	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MDM2—melanoma	1.98e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAP2K1—melanoma	1.98e-05	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—melanoma	1.96e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—melanoma	1.96e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB2—melanoma	1.95e-05	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	1.94e-05	0.000102	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—melanoma	1.93e-05	0.000101	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—melanoma	1.92e-05	0.000101	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCB1—melanoma	1.9e-05	0.0001	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF2—melanoma	1.88e-05	9.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—melanoma	1.85e-05	9.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—melanoma	1.84e-05	9.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—melanoma	1.81e-05	9.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1B—melanoma	1.81e-05	9.52e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—melanoma	1.79e-05	9.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NRAS—melanoma	1.79e-05	9.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—melanoma	1.79e-05	9.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—melanoma	1.77e-05	9.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—melanoma	1.77e-05	9.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	1.77e-05	9.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—melanoma	1.76e-05	9.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MDM2—melanoma	1.76e-05	9.27e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PRKCA—melanoma	1.75e-05	9.21e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—melanoma	1.74e-05	9.14e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ERCC2—melanoma	1.73e-05	9.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB2—melanoma	1.73e-05	9.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—melanoma	1.73e-05	9.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—melanoma	1.71e-05	9.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—melanoma	1.71e-05	9.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CTNNB1—melanoma	1.71e-05	9e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—melanoma	1.67e-05	8.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—melanoma	1.67e-05	8.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—melanoma	1.67e-05	8.78e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—melanoma	1.67e-05	8.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NFKB1—melanoma	1.66e-05	8.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—melanoma	1.64e-05	8.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—melanoma	1.63e-05	8.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK1—melanoma	1.63e-05	8.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—melanoma	1.63e-05	8.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—melanoma	1.62e-05	8.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	1.61e-05	8.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	1.59e-05	8.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—melanoma	1.57e-05	8.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—melanoma	1.57e-05	8.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—melanoma	1.56e-05	8.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—melanoma	1.54e-05	8.11e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—melanoma	1.53e-05	8.07e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	1.52e-05	7.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—melanoma	1.5e-05	7.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—melanoma	1.49e-05	7.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—melanoma	1.49e-05	7.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NRAS—melanoma	1.49e-05	7.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	1.48e-05	7.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—melanoma	1.48e-05	7.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NFKB1—melanoma	1.47e-05	7.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—melanoma	1.44e-05	7.6e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.44e-05	7.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—melanoma	1.42e-05	7.49e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—melanoma	1.42e-05	7.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	1.42e-05	7.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—melanoma	1.38e-05	7.29e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—melanoma	1.37e-05	7.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—melanoma	1.37e-05	7.21e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK1—melanoma	1.35e-05	7.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—melanoma	1.35e-05	7.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—melanoma	1.34e-05	7.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—melanoma	1.32e-05	6.97e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—melanoma	1.32e-05	6.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRAS—melanoma	1.32e-05	6.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—melanoma	1.31e-05	6.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—melanoma	1.28e-05	6.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—melanoma	1.26e-05	6.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—melanoma	1.25e-05	6.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—melanoma	1.23e-05	6.47e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—melanoma	1.2e-05	6.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK1—melanoma	1.2e-05	6.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—melanoma	1.2e-05	6.33e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—melanoma	1.19e-05	6.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	1.17e-05	6.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—melanoma	1.16e-05	6.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—melanoma	1.14e-05	5.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—melanoma	1.14e-05	5.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—melanoma	1.09e-05	5.72e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—melanoma	1.05e-05	5.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	1.04e-05	5.5e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—melanoma	1.04e-05	5.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—melanoma	1.04e-05	5.48e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—melanoma	1.01e-05	5.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—melanoma	9.65e-06	5.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—melanoma	9.6e-06	5.05e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—melanoma	9.24e-06	4.87e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—melanoma	9.07e-06	4.78e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—melanoma	8.52e-06	4.49e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—melanoma	6.4e-06	3.37e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—melanoma	5.23e-06	2.75e-05	CbGpPWpGaD
